iBio Company
iBio is a technology platform that develops pharmaceutical product applications.
Investment Stage:
N/A
Founded Date:
2008-04-01
Investor Type:
N/A
Estimated Revenue:
Less than $1M
Total Funding:
12265000
Employee Number:
1-10
Number Of Exists:
N/A
Last Funding Type:
Post-IPO Equity
Industry:
Pharma Tech
Technology:
COVID
Headquarters:
Newark, Delaware, United States
Funding Status:
N/A
Last Funding Date:
2016